Prev Arrow Stocks

Doximity, Inc. ($DOCS) Stock Forecast: Up 12.4% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Doximity, Inc.?

DOCS is the ticker symbol for Doximity, a company that operates an online networking service for medical professionals. The company provides a platform for communication, collaboration, and information sharing among healthcare providers.

Why is Doximity, Inc. going up?

DOCS stock is up 12.4% on Aug 8, 2025 19:51

  • Doximity's stock experienced a strong bullish movement following its Q1 earnings report, where it surpassed revenue and earnings expectations. This positive performance likely boosted investor confidence in the company's growth prospects.
  • Despite a decrease in gross margin, the overall revenue growth and raised full-year forecast contributed to the stock's upward momentum.
  • The acquisition of Pathway Medical for $63 million to enhance doctors' access to AI-powered clinical reference tools could have also fueled optimism among investors about Doximity's future expansion and innovation in the healthcare sector.
  • The unusual options activity showing a majority of traders taking bullish positions further indicates a positive sentiment surrounding Doximity's stock, potentially driving its upward trajectory.

DOCS Price Chart

DOCS Technical Analysis

DOCS News

DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down

Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.

https://www.zacks.com/stock/news/2684598/docs-stock-up-in-pre-market-post-q1-earnings-beat-gross-margin-down

0 Missing News Article Image DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings - Doximity ( NYSE:DOCS )

Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of 36 cents per share which beat the analyst consensus estimate of 30 cents per share.

https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/47003348/doximity-analysts-increase-their-forecasts-after-strong-q1-earnings

1 News Article Image Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings - Doximity  ( NYSE:DOCS )

Doximity ( DOCS ) Q1 Earnings and Revenues Top Estimates

Doximity (DOCS) delivered earnings and revenue surprises of +16.13% and +4.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2680512/doximity-docs-q1-earnings-and-revenues-top-estimates

2 Missing News Article Image Doximity  ( DOCS )  Q1 Earnings and Revenues Top Estimates

Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Pathway's AI-powered clinical reference tool helps doctors answer questions about guidelines, drugs and trials.

https://www.cnbc.com/2025/08/07/doximity-acquires-ai-startup-pathway-medical-for-63-million.html

3 Missing News Article Image Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Doximity Unusual Options Activity For August 07 - Doximity ( NYSE:DOCS )

Financial giants have made a conspicuous bullish move on Doximity. Our analysis of options history for Doximity DOCS revealed 11 unusual trades. Delving into the details, we found 63% of traders were bullish, while 27% showed bearish tendencies.

https://www.benzinga.com/insights/options/25/08/46978693/doximity-unusual-options-activity-for-august-07

4 News Article Image Doximity Unusual Options Activity For August 07 - Doximity  ( NYSE:DOCS )

Doximity, Inc. Price History

08.07.2025 - DOCS Stock was up 12.4%

  • Doximity's stock experienced a strong bullish movement following its Q1 earnings report, where it surpassed revenue and earnings expectations. This positive performance likely boosted investor confidence in the company's growth prospects.
  • Despite a decrease in gross margin, the overall revenue growth and raised full-year forecast contributed to the stock's upward momentum.
  • The acquisition of Pathway Medical for $63 million to enhance doctors' access to AI-powered clinical reference tools could have also fueled optimism among investors about Doximity's future expansion and innovation in the healthcare sector.
  • The unusual options activity showing a majority of traders taking bullish positions further indicates a positive sentiment surrounding Doximity's stock, potentially driving its upward trajectory.

13.04.2025 - DOCS Stock was up 5.6%

  • Doximity's strong bullish movement today can be attributed to the market's positive anticipation of its Q4 earnings report reflecting strong product momentum.
  • The company's focus on introducing new modules and integrated programs likely contributed to the market's optimism, indicating potential revenue growth.
  • The early revenue pull-forward might have also reassured investors about the company's financial performance, further fueling the bullish movement in the stock price.
  • Overall, Doximity's strategic initiatives and product-driven gains seem to have resonated well with investors, driving the stock higher in today's trading session.

08.07.2025 - DOCS Stock was up 13.3%

  • Earnings for the first quarter exceeded analyst expectations significantly, leading to a positive impact on the company's stock performance.
  • The acquisition of Pathway Medical for $63 million aims to improve doctors' access to AI-powered clinical reference tools, demonstrating Doximity's focus on expanding its services and embracing technological advancements in healthcare.
  • Strong interest in bullish options trading indicates a positive outlook on Doximity, reflecting confidence in the company's future.
  • The combination of strong earnings, strategic acquisitions, and positive market sentiment likely drove DOCS to experience significant bullish movement.

08.07.2025 - DOCS Stock was up 9.8%

  • This quarter, Doximity (DOCS) surpassed earnings and revenue forecasts, demonstrating a strong financial performance.
  • The recent acquisition of Pathway Medical for $63 million highlights a strategic move into AI-powered tools for healthcare professionals, potentially enhancing the company's technological offerings and market reach.
  • Noteworthy options trading patterns, with a prevalence of bullish positions, suggest an increasing investor faith in Doximity's future prospects, which likely played a role in the uptick in the stock price.

02.06.2025 - DOCS Stock was down 1.5%

  • There is a positive upward trend in Doximity's stock price, suggesting potential investor interest or confidence in the company.
  • Conversely, the significant downward movement in DOCS today may be linked to investors seizing profits following a recent uptick in the stock price.
  • It is plausible that investors may have responded to broader market conditions or specific developments in the healthcare sector, causing downward pressure on DOCS.
  • Despite the recent favorable movement in Doximity's stock price, today's bearish turn may be a brief adjustment influenced by various market conditions.

05.05.2025 - DOCS Stock was up 5.1%

  • Despite a recent 4.4% decline in the stock price, Doximity posted strong Q4 results, margin gains, and raised guidance, indicating a positive outlook for the company.
  • The surge in revenue growth and record user engagement can be attributed to the increasing demand for telehealth services, which have become essential in the current healthcare landscape.
  • While other tech stocks like CrowdStrike Holdings, Inc. experienced a decline in pre-market trading after reporting their first-quarter results, Doximity's focus on telehealth solutions seems to be driving its sales and market performance upwards.

05.05.2025 - DOCS Stock was up 5.1%

  • Doximity's strong Q4 revenue growth and record user engagement indicate a growing demand for telehealth and AI tools, driving investor confidence in the stock.
  • The bullish movement in DOCS could be attributed to the increasing reliance on telehealth services, especially during the current global health crisis, leading to higher adoption rates and revenue for the company.
  • While other tech stocks like CrowdStrike are facing downward pressure due to mixed earnings reports, Doximity's focus on the booming telehealth sector seems to be resonating well with investors, propelling the stock higher.

18.06.2025 - DOCS Stock was down 4.6%

  • Despite Doximity (DOCS) closing higher than the previous day, the stock experienced a bearish movement overall.
  • The increase in options trading activity around DOCS stock might indicate uncertainty or speculation among investors.
  • This mixed market behavior could suggest that while there is interest in the company, there may be underlying concerns or factors impacting the stock price negatively.
  • The bullish close followed by a bearish movement could be attributed to profit-taking by investors after the recent price increase, leading to a downward trend in the market.

17.05.2025 - DOCS Stock was up 2.5%

  • Embedding AI tools and clinical workflows into its platform has successfully increased client retention for Doximity.
  • This innovative strategy has likely elevated the platform's value proposition for medical professionals, leading to higher user engagement and the acquisition of new clients.
  • Today's positive movement in DOCS stock may be a response to investors acknowledging the company's initiatives to enhance its services and solidify its market position.

16.04.2025 - DOCS Stock was down 11.4%

  • Despite bullish sentiment from deep-pocketed investors, there was no positive market movement for Doximity (DOCS) on this day.
  • Despite posting better-than-expected earnings for the fourth quarter, the stock saw a significant bearish movement, potentially driven by below-par guidance for the first quarter and full-year 2026.
  • Investor concerns were possibly raised by an investigation, which may have contributed to the stock's bearish trend.
  • Mixed reactions to Doximity's earnings and revenue surprises likely fueled volatility and downward pressure on the stock price.

16.04.2025 - DOCS Stock was down 11.4%

  • Deep-pocketed investors adopting a bullish approach towards Doximity could not prevent the bearish movement, indicating other factors at play.
  • Despite reporting better-than-expected earnings for the fourth quarter, analysts cutting their forecasts may have spooked investors and contributed to the downward trend.
  • The investigation by a shareholder rights law firm could have raised concerns among investors about potential legal issues impacting the company's future performance.
  • While Doximity surpassed Q4 earnings and revenue estimates, the stock still experienced a dive, possibly due to the guidance for the first quarter and full-year 2026 falling below analyst expectations.

16.04.2025 - DOCS Stock was down 17.3%

  • Doximity (DOCS) surpassed Q4 earnings and revenue estimates, indicating strong financial performance.
  • However, the stock dived as the guidance for the first quarter and full-year 2026 came in below analyst expectations, leading to investor concerns.
  • Investigations by law firms into potential claims against Doximity's officers and directors might have added to the negative sentiment surrounding the stock.
  • The market reaction suggests that while the company's product momentum was strong in Q4, concerns about future growth and leadership decisions are weighing on investor confidence, contributing to the bearish movement.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.